Genuine Novo Nordisk Wegovy Dose Conversion Guide

pricing for mounjaro and wegovy weight loss

Switching from Mounjaro to Wegovy requires careful dose conversion planning with genuine medication you can trust. Both prescription-only medicines work differently—Mounjaro contains tirzepatide (GIP + GLP-1 dual agonist) whilst Wegovy contains semaglutide (GLP-1 receptor agonist only). Your prescriber will determine the appropriate Wegovy starting dose based on your current Mounjaro response and tolerance. At EverydayMeds, we supply 100% authentic Novo Nordisk Wegovy through MHRA-regulated channels, with starter doses from £79.99 using code FIRST40 at checkout. Our clinical team ensures batch-traceable, genuine FlexTouch pens sourced exclusively from licensed UK wholesalers, protecting you from the growing counterfeit semaglutide market that poses serious health risks.

  • 100% genuine Novo Nordisk Wegovy with full batch traceability from licensed UK wholesalers
  • Complete dose conversion guidance from Mounjaro's dual-action tirzepatide to Wegovy's GLP-1-only mechanism
  • UK-authorised supply chain protecting against MHRA-warned counterfeit semaglutide products
  • Next-day cold-chain delivery with prescriber review within 24-72 hours
Start your free consultation

Takes less than 2 minutes to complete, 100% online

usp of our everydaymeds for mounjaro and wegovy
pricing for mounjaro and wegovy weight loss

*Pricing shown in some areas of this page may not be up to date. Please refer to the “Our Pricing Table” or the price shown after your consultation for the latest live pricing.

Frame 1321316928.svg__PID:03074d51-9c66-4b1e-ad0f-6a0dc34acdd5
bannrimg.png__PID:519c668b-1ead-4f6a-8dc3-4acdd56dd164
bnr.svg__PID:8b1ead0f-6a0d-434a-8dd5-6dd1641b9de5
Mobile V.png__PID:3e6d948f-9181-4896-be44-1a72380b0bf4
Live Pricing

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date. The live pricing table below and the pricing shown during your consultation are our official current prices and take precedence over any other figures displayed on the site.

first30tag.svg__PID:d76478da-2741-497a-ba1b-d886bd1544e3

Why Genuine Novo Nordisk Matters For Your Dose Switch

Genuine Novo Nordisk Wegovy For Safe Mounjaro To Wegovy Dose Conversion

When considering a mounjaro to wegovy dose conversion chart, medication authenticity becomes paramount for your safety and treatment success. Counterfeit semaglutide products have flooded online markets, prompting multiple MHRA warnings about fake injectable weight management treatments containing unknown substances. EverydayMeds sources 100% genuine Novo Nordisk Wegovy exclusively from licensed UK wholesalers, ensuring every FlexTouch pen carries full batch traceability and MHRA regulatory compliance. Our supply chain verification process ensures authentic Wegovy that meets pharmaceutical manufacturing standards.

The importance of genuine medication extends beyond safety—authentic Novo Nordisk Wegovy delivers consistent semaglutide concentrations essential for predictable dose conversion outcomes. Counterfeit products may contain incorrect active ingredient levels, rendering any mounjaro to wegovy dose conversion chart meaningless and potentially dangerous. Your prescriber relies on known pharmacokinetic profiles when transitioning between medications, which requires genuine pharmaceutical-grade semaglutide. EverydayMeds' commitment to authentic Novo Nordisk Wegovy ensures your dose conversion follows established clinical protocols with reliable therapeutic effects.

Wegovy Pricing Structure For Your Mounjaro To Wegovy Dose Conversion Chart Journey

Understanding Wegovy pricing helps you plan your mounjaro to wegovy dose conversion chart transition effectively across all dose escalation phases. Single pen pricing starts at £79.99 for 0.25mg (weeks 1-4) using code FIRST40, progressing to £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), £139.99 for 1.7mg (weeks 13-16), and £209.99 for 2.4mg maintenance dosing (week 17 onwards). Returning customers benefit from code DOSE25 applied at checkout for continued savings. Our transparent pricing structure eliminates hidden costs whilst ensuring genuine Novo Nordisk quality throughout your treatment journey.

Bundle options provide convenient multi-month supply for sustained dose conversion success, including the Intro Trio (0.25mg, 0.5mg, 1mg) at £299.99 covering your initial 12-week escalation period. The Progress Trio (0.5mg, 1mg, 1.7mg) costs £369.99 for mid-stage dosing, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. Each bundle includes genuine Novo Nordisk FlexTouch pens with verified batch numbers and expiry dates. These pricing options support your mounjaro to wegovy dose conversion chart planning with predictable costs and assured authentic medication supply.

Clinical Evidence Supporting Mounjaro To Wegovy Dose Conversion Chart Decisions

The STEP clinical trial programme demonstrates Wegovy's efficacy profile that informs mounjaro to wegovy dose conversion chart protocols developed by healthcare professionals. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo. STEP 2 showed approximately 9.6% weight reduction in patients with type 2 diabetes, whilst STEP 3 demonstrated approximately clinically studied weight loss when combined with intensive behavioural therapy.

The SELECT cardiovascular outcomes trial revealed a 20% reduction in major adverse cardiovascular events (HR 0.80, 95% CI 0.72-0.90), providing additional clinical rationale for semaglutide therapy beyond weight management. These evidence-based outcomes help prescribers evaluate when a mounjaro to wegovy dose conversion chart approach may support your treatment goals. However, individual responses vary significantly, and your healthcare provider will assess personal factors when determining optimal conversion strategies.

How Wegovy Works Differently In Your Mounjaro To Wegovy Dose Conversion Chart

Understanding Wegovy's mechanism helps explain why mounjaro to wegovy dose conversion chart planning requires careful consideration of pharmacological differences. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for glucose-dependent insulin secretion and appetite regulation. Unlike Mounjaro's dual GIP/GLP-1 approach, Wegovy works exclusively through GLP-1 pathways, influencing hypothalamic appetite centres to reduce food cravings and promote satiety after smaller meals. This single-pathway mechanism may require different dosing strategies compared to Mounjaro's broader hormonal effects. The once-weekly injection schedule provides sustained semaglutide levels throughout the week, maintaining consistent appetite suppression and metabolic benefits that support long-term weight management alongside reduced-calorie diet and increased physical activity.

Streamlined Ordering Process For Your Mounjaro To Wegovy Dose Conversion Chart

Beginning your mounjaro to wegovy dose conversion chart journey with EverydayMeds starts with our comprehensive 3-minute online clinical assessment covering your current Mounjaro experience, medical history, and conversion goals. Our UK-registered prescribers (GPhC #9012878) review your assessment within standard 3 working days or express 24-hour service, ensuring appropriate dose selection based on your individual circumstances and Mounjaro treatment response. Once approved, genuine Novo Nordisk Wegovy ships via next-day delivery using temperature-controlled cold-chain logistics that maintain pharmaceutical integrity from our facility to your door. This streamlined process eliminates clinic visits whilst maintaining clinical oversight essential for safe medication transitions. Your prescription-only medicine arrives with comprehensive dosing instructions and ongoing support throughout your treatment journey.

Storage Advantages And Practical Considerations For Mounjaro To Wegovy Dose Conversion Chart Success

Wegovy's superior storage flexibility provides practical advantages when following your mounjaro to wegovy dose conversion chart protocol, especially during travel or lifestyle changes. Whilst requiring refrigeration at 2-8°C before first use, Wegovy pens remain stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration—significantly longer than Mounjaro's 21-day room temperature limit. The genuine Novo Nordisk FlexTouch pen design ensures accurate dose delivery with audible and tactile feedback confirming successful injection completion. Your mounjaro to wegovy dose conversion chart will follow mandatory escalation phases starting at 0.25mg for 4 weeks, preventing gastrointestinal side effects whilst optimising therapeutic response. Each authentic Wegovy pen displays clear batch numbers, expiry dates, and Novo Nordisk branding that verify genuine pharmaceutical quality.

Authentic Novo Nordisk Verification For Mounjaro To Wegovy Dose Conversion Chart Safety

Protecting yourself from counterfeit semaglutide requires understanding how to verify genuine Novo Nordisk Wegovy when implementing your mounjaro to wegovy dose conversion chart. Authentic FlexTouch pens feature specific visual indicators including crisp Novo Nordisk logos, clear batch number printing, and precise injection mechanism functionality that counterfeit products cannot replicate accurately. The packaging includes tamper-evident seals, pharmaceutical-grade labelling, and QR codes linking to Novo Nordisk's verification systems. MHRA warnings highlight increasing seizures of fake semaglutide products containing harmful substances or incorrect concentrations that render dose conversion protocols dangerous.

EverydayMeds' supply chain documentation provides complete traceability from Novo Nordisk manufacturing facilities through licensed UK wholesaler networks to your delivery address. Each Wegovy pen includes a patient information leaflet with genuine Novo Nordisk contact details and adverse event reporting procedures. This authentication process ensures your mounjaro to wegovy dose conversion chart follows established clinical parameters with pharmaceutical-grade medication. Suspicious products lacking proper documentation, sold at significantly reduced prices, or obtained from unlicensed sources pose serious health risks and should be avoided completely.

Complete Your Mounjaro To Wegovy Dose Conversion Chart With Confidence

Starting your authentic Novo Nordisk Wegovy journey requires just a few simple steps through our secure online platform designed specifically for prescription-only medicine dispensing. New customers save with code FIRST40 whilst returning customers use DOSE25, both applied automatically at checkout to reach our published pricing. Your mounjaro to wegovy dose conversion chart begins with clinical assessment completion, prescriber approval, and next-day genuine medication delivery—all backed by our GPhC #9012878 registration and MHRA compliance standards. Visit https://everydaymeds.co.uk/collections/wegovy to begin your transition with complete confidence in medication authenticity and clinical oversight. Our commitment to genuine Novo Nordisk Wegovy ensures your dose conversion follows established pharmaceutical standards with predictable therapeutic outcomes and comprehensive safety monitoring throughout your weight management journey.

Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026

How it
Works?

Group 469326.png__PID:d1d71928-56cc-4f79-bdc7-0a45d0bc6b99
Background (1).png__PID:62282697-4455-4e74-a869-705c14f98b30
Background (3).png__PID:72aeaaf6-bb5b-4dd5-8914-6efdf80a1555

Start your assessment for Weight Loss

Start your journey to better health today.

List.svg__PID:b4a5b990-cf62-48e4-ba8f-0a8bffce6cc6

Start your journey to better health today.

Once you complete a short online assessment, you’ll be able to choose your preferred treatment and quantity from a list of safe, medically approved options tailored to you.

Start My Assessment

Returning customer?

Log in to Your Account

Frequently Asked Question